| S.No | Ongoing Projects |
| 1 | Prospective, randomized, double blind, two arm, placebo controlled comparative clinical study to evaluate the efficacy and safety liv 52DS tablets in metabolic dysfunction – associated fatty liver disease (MAFLD). |
| 2 | A Phase III, Multi-Center, Randomized, Double Blind, Active - Controlled, Parallel group study to evaluate the Efficacy and Safety of Vonoprazan 20mg tablets compared to Pantoprazole 40mg tablets in Patients with Gastroesophageal Reflux Diseases (GERD) |
| S.No | Faculty Names | Publications |
| 1 | Nanda RA and Mohammed A | Mucosal healing after high dose pantoprazole in acut corrosive injury of esophagus -Journal of Med Allied Sci. 2020; 10(2) |
| 2 | Renuka Prasad, K., Chettri, P., Rajesh, N.A. et al. | Assessment of the risk of acute kidney injury associated with the use of pantoprazole and esomeprazole. Drugs Ther Perspect 34, 223–230 (2018). https://doi.org/10.1007/s40267-018-0503-5 |
| 3 | Kumaran SV, Amarnath RN, Ali M, Pugazhendhi T.(2020). | Comparison of Fatty Meal, Drotaverine and Hyoscine for Duodenal Anti-motility and Cannulation During ERCPA Randomised Controlled Trial, 14(11), OC14-OC18. https://www.doi.org/10.7860/JCDR/2020/45986/14222 |
| 4 | NANDA Rajesh A.; GEORGE Melvin. | Prevalence of duodenal ulcer and associated Helicobacter pylori infection in chronic liver disease. International Journal of Research in Medical Sciences, [S.l.], v. 8, n. 12, p. 4442-4446, nov. 2020. ISSN 2320-6012. |
| 5 | Rajesh NA, Drishya L, Ambati MMR, Narayanan AL, Alex M, R KK, Abraham JJ, Vijayakumar TM. | Safety and Efficacy of Saroglitazar in Nonalcoholic Fatty Liver Patients With Diabetic Dyslipidemia-A Prospective, Interventional, Pilot Study. J Clin Exp Hepatol. 2022 Jan-Feb;12(1):61-67. doi: 10.1016/j.jceh.2021.03.012. Epub 2021 Apr 9. PMID: 35068786; PMCID: PMC8766544. |
| 6 | Nanda, Rajesh Amarnath; Krishnan, Karthikeyan; Kothagundu, Vaibhavi; Reddy, Chegireddy Mahindranath; Mathew, Sunitha Elza; Chandran, Geethika. | Clarithromycin versus Levofloxacin Based Triple Drug Therapy as First Line Eradication for Helicobacter pylori Infection- A Randomised Clinical Study. Journal of Clinical & Diagnostic Research . Jun2022, Vol. 16 Issue 6, p26-29. 4p. |
| 7 | S. Muthukaruppankaruppiah, S. Rajendiran Nagalingam, P. Murugasen and R. Nandaamarnath, | "Human fatty liver monitoring using nano sensor and iomt," Intelligent Automation & Soft Computing, vol. 35, no.2, pp. 2309–2323, 2023. |
| 8 | Navakanth Raju Ramayanam, Rajesh Nanda Amarnath, Thangavel Mahalingam Vijayakumar. | Pharmacogenetic Biomarkers and Personalized Medicine: Upcoming Concept in Pharmacotherapy. Research Journal of Pharmacy and Technology. 2022; 15(9):4289-2. doi: 10.52711/0974-360X.2022.00720 |
| 9 | Navakanth Raju Ramayanam, Vijayakumar Thangavel Mahalingam, Rajesh Nanda Amarnath, & Vasanth Konda Mohan. (2022). | Influence of Pharmacokinetics in Responders and Non-Responders of Prednisolone Based Therapy in Alcoholic Hepatitis Patients. Journal of Pharmaceutical Negative Results, 363–371. https://doi.org/10.47750/pnr.2022.13.S01.45 |
| 10 | Navakanth Raju Ramayanam, Rajesh Nanda Amarnath, Mohan Kumar Ramasamy, Thangavel Mahalingam Vijayakumar (2023). | Emerging corticosteroid resistance : Need for customized medication based on pharmacogenomics profiling. Journal of Applied Pharmaceutical Science Vol0(00), pp 001-010,2023. http://www.japsonline.com (10.01.2023 Publised) |
| 11 | Nidhi Mariam George, Nanda Amarnath Rajesh, Tharun Ganapathy Chitrambalam (August 2023) | Acute Pancreattitis following Endoscopic Ampullary Biopsy : A Case report. World Journal of Gastrointestinal Endoscopy Volume (15), Issue 8 pg: 540-544 https://www.wjgnet.com (10.4253 /wjge.v15.i8.540) ISSN 1948-5190(Online) |
| 12 | Rajesh Nanda Amarnath | Diabetes Mellitus and IPSC Based therapy Advances in Diabetes Research and Management. 978981190027J, Jan 2023, Scopus - Book Chapter. |
| 13 | Rajesh Nanda Amarnath | Clinical profile of 1208 newly diagnosed colorectal cancer patients in Tamil Nadu – A multicentric survey – 19 February 2024 – Indian Journal of Gastroenterology |
| 14 | Navakanth Raju Ramayana, Rajesh Nanda Amarnath, Vijayakumar Thangavel Mahalingam. | Prevalence of alcoholic hepatitis and corticosteroid resistance in urban south Indians : A cross sectional study. Published Online - 08th March 2024 – Pharmacy practice 2024. (eISSN : 1886-3655 ISSN : 1885 – 642X). |
| S. No | Completed Projects |
| 1 | A prospective, Randomized, Double – Blind, Two arm, Placebo Controlled Comparative Clinical Study to Evaluate the Efficacy and Safety of Liv.52 DS tablets in Metabolic Dysfunction – Associated fatty Liver Disease (MAFLD) : An Exploratory study. |
| S.No | Awards |
| 1 | State First in DM entrance Examination |
| 2 | Clinical Observership& Hands-on Training in Third Space Endoscopy West China Hospital, Chengdu – 2019 |
| 3 | Postgraduate Gastroenterology CertificateAmerican College of Gastroenterology - 2019 |
| 4 | Golden AIM Award for Excellence &Leadershipin Healthcare Nov 2020-Innovative Healthcare Leadership Award - Gastroenterologist |
| 5 | Third prize in ENDOPAEDIA – Best endoscopy video award in GASTROCON 2022 – Indian Society of Gastroenterology. |
I would really like to recommend Dr. Rajesh for his work and dedication and he deserves honor and respect.
I am normal after 2 days of treatment for severe stomach pain, perfect diagnosis and treatment.
Doctor is nice and humble and has outstanding behavior with patients.
Doctor is very good, Outstanding behavior with patients, no 1 gastroenterologist.
Never recommend too many test, only the minimum precise ones are required, I found the prescribed medicines to be quite effective.
